Author name: Niall Slowey

Free Paper Focus: FAF imaging underestimates retinal displacement

Fundus autofluorescence (FAF) does not demonstrate the full extent of retinal displacement that is present following pars plana vitrectomy for rhegmatogenous retinal detachment (RRD) repair and reveals only the “tip of the iceberg”, according to a study presented at the 22nd EURETINA Congress. “Furthermore, although FAF detects the presence of retinal displacement with excellent specificity, …

Free Paper Focus: FAF imaging underestimates retinal displacement Read More »

Symposium showcases cutting-edge retinal research

A diverse range of topics from the role of blood flow in diabetic retinopathy to a new pipeline treatment for central retinal artery occlusion and an update on the risk of vasculitis after brolucizumab injections were some of the key themes covered in the EURETINA research session. Chaired by Prof Reinier Schlingemann and Prof Martin …

Symposium showcases cutting-edge retinal research Read More »

Making headway in the battle against inherited retinal diseases

Recent research and developments in gene therapy and cell therapy have shown therapeutic promise in a range of inherited retinal diseases (IRDs), many of which are currently incurable and lead to irreversible vision loss, delegates attending the EURETINA session were told. Chaired by Bart Leroy and Isabelle Audo, the session was opened by Alberto Auricchio …

Making headway in the battle against inherited retinal diseases Read More »

New treatments changing tumour treatment landscape

Potentially groundbreaking new treatments for uveal melanoma, retinoblastoma and melanocytic lesions were among the noteworthy recent developments highlighted in the EURETINA session on tumours. Chaired by Jens Folke Kiilgaard and Heinrich Heimann, delegates were brought up to date on some of the exciting drugs and new techniques emerging from clinical trials to help manage difficult …

New treatments changing tumour treatment landscape Read More »

EURETINA video awards highlight surgical skill

An innovative technique to rescue a black nucleus after failed cataract surgery and the utility of using subretinal lavage in persistent subretinal fluid after retinal detachment repair were among some of the vitreoretinal surgical techniques showcased in the 2022 EURETINA Video Awards, with the very high standard of entries this year praised by Frank Holz, …

EURETINA video awards highlight surgical skill Read More »

Free Paper Focus: Real-world data confirms promise of ocular gene therapy

The latest data from the ongoing PERCEIVE study seems to be consistent with the findings of clinical trials of voretigene neparvovec (VN), the first approved ocular gene therapy for patients with RPE65-mediated inherited retinal dystrophy and sufficient viable retinal cells. “Based on this year 2 interim analysis, the PERCEIVE study demonstrates the safety and effectiveness …

Free Paper Focus: Real-world data confirms promise of ocular gene therapy Read More »

Exciting updates announced in Late Breaking session

A host of exciting data and potentially ground-breaking results which could make a real impact on clinical care for a wide range of retinal diseases were featured at the Late Breaking News session at EURETINA. Global Survey on Management of DME and DR Chaired by Ramin Tadayoni, Jose García Arumí and Kourous Rezaei, the session …

Exciting updates announced in Late Breaking session Read More »

Kreissig Lecture Preview: Retinal Mobility and Plasticity in Retinal Surgery

Professor Hiroko Terasaki will deliver the Kreissig Award Lecture in Hall 1 (Level 2) at 12:30 on Saturday 3 September 2022. Lecture highlights key questions about retinal mobility and plasticity. The ways in which recent advances in imaging technologies have helped to enhance our understanding of fundamental questions concerning retinal mobility and plasticity in retinal …

Kreissig Lecture Preview: Retinal Mobility and Plasticity in Retinal Surgery Read More »

Gisbert Richard Lecture Preview: Macular surgery enters era of tailored treatment

Catherine Creuzot-Garcher MD, PhD, FEBO will deliver the Gisbert Richard Lecture in Hall 1 (Level 2) at 13:00 on Saturday 3 September 2022.  The principal outcomes and complications of macular surgery is the vast theme of the Gisbert Richard Lecture to be delivered by Catherine Creuzot-Garcher MD, PhD, FEBO at the 22nd EURETINA Congress. In …

Gisbert Richard Lecture Preview: Macular surgery enters era of tailored treatment Read More »